| 1 | [Glentek 50 mg compresse rivestite con film] | - | - | - | - | [1] 18 18 💬
|
| 2 | [J05AG04] | - | - | - | - | [1] 18 18 💬
|
| 3 | [PTC743] | - | - | - | - | [2] 18 18, 21 💬
|
| 4 | [VO659] | [1] VO659 VO659 | - | - | - | [2] 8 8, 18 💬
|
| 5 | AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV) gene transfer vector expressing the cDNA coding for human FXN | - | - | - | - | [1] 18 18 💬
|
| 6 | Alpha-tocotrienol quinone | [2] Tocotrienol Tocotrienol, Vatiquinone | [1] Vatiquinone
Vatiquinone
💬
| - | - | [3] 18 18, 21, 156 💬
|
| 7 | Alpha-tocotrienolquinone | - | - | - | - | [1] 18 18 💬
|
| 8 | Antrodia cinnamomea Products | - | - | - | - | [1] 18 18 💬
|
| 9 | ARO-ATXN2 Injection | - | - | - | - | [1] 18 18 💬
|
| 10 | Artesunate | [1] Artesunate Artesunate | [1] Artesunate
Artesunate
💬
| - | - | [4] 18 18, 66, 86, 96 💬
|
| 11 | Artesunate Oral Product | [1] Artesunate Artesunate | [1] Artesunate
Artesunate
💬
| - | - | [1] 18 18 💬
|
| 12 | Baclofen | [1] Baclofen Baclofen | [1] Baclofen
Baclofen
💬
| [2] GABBR1 GABBR1, GABBR2 💬
| [8] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [8] 2 2, 10, 13, 18, 65, 70, 149, 206 💬
|
| 13 | Behavioral: Aerobic Training | - | - | - | - | [1] 18 18 💬
|
| 14 | Behavioral: Balance Training | - | - | - | - | [3] 6 6, 13, 18 💬
|
| 15 | Behavioral: Balance training by means of conventional rehabilitation | - | - | - | - | [1] 18 18 💬
|
| 16 | Behavioral: Balance training over stabilometric platform | - | - | - | - | [1] 18 18 💬
|
| 17 | Behavioral: High-Intensity Aerobic Exercise Prior to Balance Training | - | - | - | - | [1] 18 18 💬
|
| 18 | Behavioral: Low-Intensity Exercise Prior to Balance Training | - | - | - | - | [1] 18 18 💬
|
| 19 | Behavioral: Tai chi | - | - | - | - | [1] 18 18 💬
|
| 20 | BHV-4157 | - | - | - | - | [1] 18 18 💬
|
| 21 | BIIB132 | - | - | - | - | [1] 18 18 💬
|
| 22 | BINOCRIT*1SIR 40000UI/1ML | - | - | - | - | [1] 18 18 💬
|
| 23 | Bupropion | [1] Bupropion Bupropion | [3] Bupropion hydrochloride
Bupropion hydrochloride
,
Bupropion
,
Bupropion hydrobromide
💬
| [2] SLC6A2 SLC6A2, SLC6A3 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [7] 8 8, 18, 21, 96, 97, 171, 298 💬
|
| 24 | Bupropion & Citalopram | [2] Bupropion Bupropion, Citalopram | [5] Bupropion hydrochloride
Bupropion hydrochloride
,
Citalopram hydrobromide
,
Bupropion
,
Citalopram
,
Bupropion hydrobromide
💬
| [3] SLC6A2 SLC6A2, SLC6A3, SLC6A4 💬
| [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 18 18 💬
|
| 25 | C-Trelin OD Tab(5mg Taltirelin Hydrate) | [1] Taltirelin Taltirelin | - | - | - | [1] 18 18 💬
|
| 26 | Cabaletta for IV infusion once weekly during 24 weeks | - | - | - | - | [1] 18 18 💬
|
| 27 | CAD-1883 | - | - | - | - | [1] 18 18 💬
|
| 28 | Calcitriol | [1] Calcitriol Calcitriol | [1] Calcitriol
Calcitriol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [11] 18 18, 37, 46, 49, 66, 96, 158, 223, 235, 238, 326 💬
|
| 29 | Chinese medicine WT | - | - | - | - | [1] 18 18 💬
|
| 30 | Citalopram | [1] Citalopram Citalopram | [2] Citalopram hydrobromide
Citalopram hydrobromide
,
Citalopram
💬
| [1] SLC6A4 SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [7] 6 6, 8, 13, 18, 46, 98, 127 💬
|
| 31 | Coenzyme Q10 | - | - | - | - | [11] 2 2, 5, 6, 8, 10, 18, 49, 57, 107, 113, 193 💬
|
| 32 | Conventional medicine | - | - | - | - | [1] 18 18 💬
|
| 33 | CTI-1601 | - | - | - | - | [1] 18 18 💬
|
| 34 | DEFERIPRONE | [1] Deferiprone Deferiprone | [1] Deferiprone
Deferiprone
💬
| - | - | [7] 2 2, 6, 18, 121, 122, 139, 233 💬
|
| 35 | DHA | - | - | - | - | [1] 18 18 💬
|
| 36 | Diagnostic Test: Blood analysis for hypercalcemia's control | - | - | - | - | [1] 18 18 💬
|
| 37 | Diagnostic Test: Blood Draw - Baseline | - | - | - | - | [1] 18 18 💬
|
| 38 | Diagnostic Test: Blood Draw - Follow-up 12 months | - | - | - | - | [1] 18 18 💬
|
| 39 | Diagnostic Test: Blood Draw - Follow-up 24 months | - | - | - | - | [1] 18 18 💬
|
| 40 | Diagnostic Test: Buccal Swabs and Blood Draws | - | - | - | - | [1] 18 18 💬
|
| 41 | Diagnostic Test: Buccal Swabs, Blood Draws and Skin Punch Biopsy | - | - | - | - | [1] 18 18 💬
|
| 42 | Diagnostic Test: Clinical Scales - Baseline | - | - | - | - | [1] 18 18 💬
|
| 43 | Diagnostic Test: Clinical Scales - Follow-up 12 months | - | - | - | - | [1] 18 18 💬
|
| 44 | Diagnostic Test: Clinical Scales - Follow-up 24 months | - | - | - | - | [1] 18 18 💬
|
| 45 | Diagnostic Test: Molecular Diagnosis | - | - | - | - | [1] 18 18 💬
|
| 46 | Diagnostic Test: Quality of Life Assessment - Baseline | - | - | - | - | [1] 18 18 💬
|
| 47 | Diagnostic Test: Quality of Life Assessment - Follow-up 12 months | - | - | - | - | [1] 18 18 💬
|
| 48 | Diagnostic Test: Quality of Life Assessment - Follow-up 24 months | - | - | - | - | [1] 18 18 💬
|
| 49 | DT-216 | - | - | - | - | [1] 18 18 💬
|
| 50 | DT-216P2 | - | - | - | - | [1] 18 18 💬
|
| 51 | EGB 761 (r) 120 mg | - | - | - | - | [1] 18 18 💬
|
| 52 | EGb 761 120 mg | - | - | - | - | [1] 18 18 💬
|
| 53 | Elamipretide | [1] Elamipretide Elamipretide | [2] Elamipretide
Elamipretide
,
Elamipretide hydrochloride
💬
| - | - | [3] 18 18, 21, 324 💬
|
| 54 | Epoeitin beta | - | - | - | - | [1] 18 18 💬
|
| 55 | Epoetin alfa | - | - | - | - | [3] 13 13, 18, 46 💬
|
| 56 | EPREX*1FL 40000UI/ML 1ML | - | - | - | - | [1] 18 18 💬
|
| 57 | EPREX*1SIR 10000UI 1ML | - | - | - | - | [1] 18 18 💬
|
| 58 | EPREX*1SIR 40000UI/ML 1ML | - | - | - | - | [2] 2 2, 18 💬
|
| 59 | ERYTHROPOIETIN | [1] Erythropoietin Erythropoietin | [4] Epoetin alfa
Epoetin alfa
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| [1] EPOR EPOR 💬
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [11] 2 2, 6, 13, 18, 22, 47, 61, 63, 70, 95, 96 💬
|
| 60 | ETRAVIRINA | - | - | - | - | [1] 18 18 💬
|
| 61 | Etravirine | [1] Etravirine Etravirine | [1] Etravirine
Etravirine
💬
| - | - | [1] 18 18 💬
|
| 62 | Etravirine Tablets | [1] Etravirine Etravirine | [1] Etravirine
Etravirine
💬
| - | - | [1] 18 18 💬
|
| 63 | EU1/97/031-032 | - | - | - | - | [1] 18 18 💬
|
| 64 | EU1/97/031/031-032 | - | - | - | - | [1] 18 18 💬
|
| 65 | Excipients | - | - | - | - | [1] 18 18 💬
|
| 66 | Fampridine 10 mg prolonged-release tablet (per os) | - | - | - | - | [1] 18 18 💬
|
| 67 | Flumazenil | [1] Flumazenil Flumazenil | [1] Flumazenil
Flumazenil
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [5] 6 6, 13, 17, 18, 206 💬
|
| 68 | Fursultiamine | [1] Fursultiamine Fursultiamine | [2] Fursultiamine
Fursultiamine
,
Fursultiamine hydrochloride
💬
| - | - | [2] 6 6, 18 💬
|
| 69 | GABAPENTIN | [1] Gabapentin Gabapentin | [1] Gabapentin
Gabapentin
💬
| [5] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
| [10] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | [7] 6 6, 13, 18, 19, 70, 226, 298 💬
|
| 70 | Gabapentine 300mg | [1] Gabapentin Gabapentin | [1] Gabapentin
Gabapentin
💬
| [5] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
| [10] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | [2] 13 13, 18 💬
|
| 71 | Gamma interferon | - | - | - | - | [1] 18 18 💬
|
| 72 | GBP | - | - | - | - | [2] 13 13, 18 💬
|
| 73 | Genetic: All Participants | - | - | - | - | [1] 18 18 💬
|
| 74 | Genetic: ASP2016 | - | - | - | - | [1] 18 18 💬
|
| 75 | Genetic: High Dose LX2006 | [1] LX2006 LX2006 | - | - | - | [1] 18 18 💬
|
| 76 | Genetic: Low dose LX2006 | [1] LX2006 LX2006 | - | - | - | [1] 18 18 💬
|
| 77 | Genetic: Mid Dose LX2006 | [1] LX2006 LX2006 | - | - | - | [1] 18 18 💬
|
| 78 | Ginkgo biloba | [1] Ginkgo biloba Ginkgo biloba | [1] Ginkgo
Ginkgo
💬
| - | - | [4] 13 13, 18, 47, 90 💬
|
| 79 | Glentek 50 mg compresse rivestite con film | - | - | - | - | [1] 18 18 💬
|
| 80 | Glentek 50 mg film-coated tablets | - | - | - | - | [1] 18 18 💬
|
| 81 | Granocyte | - | - | - | - | [1] 18 18 💬
|
| 82 | H-116PI-DE.pdf | - | - | - | - | [1] 18 18 💬
|
| 83 | High-dose intravenous immunoglobulin (IVIG) | - | - | - | - | [1] 18 18 💬
|
| 84 | Idebenone | [1] Idebenone Idebenone | [1] Idebenone
Idebenone
💬
| - | - | [9] 6 6, 8, 13, 17, 18, 21, 113, 115, 302 💬
|
| 85 | Imukin | - | - | - | - | [3] 18 18, 58, 228 💬
|
| 86 | IMUKIN - 6 FLACONI 0.5 ML 100 MCG | - | - | - | - | [2] 18 18, 58 💬
|
| 87 | IMUKIN*SC 6F 0,5ML 100MCG | - | - | - | - | [1] 18 18 💬
|
| 88 | INTELENCE | - | - | - | - | [1] 18 18 💬
|
| 89 | INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE | - | - | - | - | [1] 18 18 💬
|
| 90 | Interferon Gamma | [1] Interferon Gamma Interferon Gamma | - | - | - | [9] 18 18, 65, 85, 96, 107, 228, 299, 301, 326 💬
|
| 91 | INTERFERON GAMMA-1B | [2] Interferon Gamma Interferon Gamma, Interferon gamma-1b | [1] Interferon gamma-1b
Interferon gamma-1b
💬
| [2] IFNGR1 IFNGR1, IFNGR2 💬
| [18] Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | [7] 18 18, 65, 85, 228, 299, 301, 326 💬
|
| 92 | Intranasal infusion | - | - | - | - | [1] 18 18 💬
|
| 93 | Intrathecal infusion | - | - | - | - | [1] 18 18 💬
|
| 94 | Intrathecal injection | - | - | - | - | [2] 2 2, 18 💬
|
| 95 | Intravenous Infusion | - | - | - | - | [3] 6 6, 18, 51 💬
|
| 96 | Iron | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [7] 18 18, 60, 96, 97, 238, 254, 284 💬
|
| 97 | Iron chelating intervention | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 18 18 💬
|
| 98 | IVIG | - | - | - | - | [8] 11 11, 13, 14, 18, 51, 63, 65, 172 💬
|
| 99 | KPS-0373 | - | - | - | - | [1] 18 18 💬
|
| 100 | KPS-0373, High dose | - | - | - | - | [1] 18 18 💬
|
| 101 | KPS-0373, Low dose | - | - | - | - | [1] 18 18 💬
|
| 102 | Lenograstim | [1] Lenograstim Lenograstim | [1] Lenograstim
Lenograstim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [8] 2 2, 13, 16, 18, 19, 57, 65, 97 💬
|
| 103 | Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [13] 5 5, 6, 7, 18, 19, 65, 96, 97, 127, 280, 283, 284, 299 💬
|
| 104 | LITHIUM CARBONATE | [1] Lithium carbonate Lithium carbonate | [1] Lithium carbonate
Lithium carbonate
💬
| - | - | [6] 2 2, 13, 17, 18, 127, 310 💬
|
| 105 | LITIO CARBONATO | - | - | - | - | [3] 2 2, 17, 18 💬
|
| 106 | Lu AA24493 | - | - | - | - | [1] 18 18 💬
|
| 107 | LX2006 | [1] LX2006 LX2006 | - | - | - | [1] 18 18 💬
|
| 108 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [51] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 109 | MIB-626 | - | - | - | - | [1] 18 18 💬
|
| 110 | MIN-102 | - | - | - | - | [2] 18 18, 20 💬
|
| 111 | N-Acetyl-L-Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [3] 18 18, 19, 65 💬
|
| 112 | Neo-Recormon | - | - | - | - | [1] 18 18 💬
|
| 113 | NeoRecormon | [1] Epoetin beta Epoetin beta | [1] Epoetin beta
Epoetin beta
💬
| [1] EPOR EPOR 💬
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [2] 13 13, 18 💬
|
| 114 | Nerve Growth Factor | [1] Nerve Growth Factor Nerve Growth Factor | - | - | - | [5] 2 2, 3, 18, 53, 90 💬
|
| 115 | Neurontin 300 mg hard capsule | - | - | - | - | [2] 13 13, 18 💬
|
| 116 | Nicotinamide | [1] Nicotinamide Nicotinamide | [1] Niacinamide
Niacinamide
💬
| - | - | [19] 2 2, 5, 6, 7, 8, 17, 18, 21, 46, 49, 60, 63, 65, 85, 97, 107, 162, 191, 302 💬
|
| 117 | Nicotinamide riboside | [2] Nicotinamide Nicotinamide, Nicotinamide riboside | [1] Niacinamide
Niacinamide
💬
| - | - | [14] 2 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 97, 191 💬
|
| 118 | NL-ATN1-001 | - | - | - | - | [1] 18 18 💬
|
| 119 | NL-ATN1-002 | - | - | - | - | [1] 18 18 💬
|
| 120 | Nomlabofusp | [1] Nomlabofusp Nomlabofusp | - | - | - | [1] 18 18 💬
|
| 121 | Omaveloxolone | [1] Omaveloxolone Omaveloxolone | [1] Omaveloxolone
Omaveloxolone
💬
| [1] NFE2L2 NFE2L2 💬
| [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 💬
|
| 122 | Omaveloxolone Capsules, 10 mg | [1] Omaveloxolone Omaveloxolone | [1] Omaveloxolone
Omaveloxolone
💬
| [1] NFE2L2 NFE2L2 💬
| [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 💬
|
| 123 | Omaveloxolone Capsules, 150 mg | [1] Omaveloxolone Omaveloxolone | [1] Omaveloxolone
Omaveloxolone
💬
| [1] NFE2L2 NFE2L2 💬
| [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 💬
|
| 124 | Omaveloxolone Capsules, 160 mg | [1] Omaveloxolone Omaveloxolone | [1] Omaveloxolone
Omaveloxolone
💬
| [1] NFE2L2 NFE2L2 💬
| [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 💬
|
| 125 | Omaveloxolone Capsules, 2.5 mg | [1] Omaveloxolone Omaveloxolone | [1] Omaveloxolone
Omaveloxolone
💬
| [1] NFE2L2 NFE2L2 💬
| [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 💬
|
| 126 | Omaveloxolone Capsules, 20 mg | [1] Omaveloxolone Omaveloxolone | [1] Omaveloxolone
Omaveloxolone
💬
| [1] NFE2L2 NFE2L2 💬
| [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 💬
|
| 127 | Omaveloxolone Capsules, 300 mg | [1] Omaveloxolone Omaveloxolone | [1] Omaveloxolone
Omaveloxolone
💬
| [1] NFE2L2 NFE2L2 💬
| [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 💬
|
| 128 | Omaveloxolone Capsules, 40 mg | [1] Omaveloxolone Omaveloxolone | [1] Omaveloxolone
Omaveloxolone
💬
| [1] NFE2L2 NFE2L2 💬
| [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 💬
|
| 129 | Omaveloxolone Capsules, 5 mg | [1] Omaveloxolone Omaveloxolone | [1] Omaveloxolone
Omaveloxolone
💬
| [1] NFE2L2 NFE2L2 💬
| [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 💬
|
| 130 | Omaveloxolone Capsules, 80 mg | [1] Omaveloxolone Omaveloxolone | [1] Omaveloxolone
Omaveloxolone
💬
| [1] NFE2L2 NFE2L2 💬
| [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 💬
|
| 131 | Other: Blood analysis for frataxin's level measurement | - | - | - | - | [1] 18 18 💬
|
| 132 | Other: Blood draw | - | - | - | - | [17] 2 2, 6, 11, 13, 18, 39, 46, 57, 77, 84, 85, 86, 88, 96, 97, 167, 299 💬
|
| 133 | Other: Exercise intervention | - | - | - | - | [3] 13 13, 18, 60 💬
|
| 134 | Other: Spinal tap for CSF collection | - | - | - | - | [1] 18 18 💬
|
| 135 | Other: Venipuncture for blood sample | - | - | - | - | [1] 18 18 💬
|
| 136 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 137 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 138 | PS659 | - | - | - | - | [2] 8 8, 18 💬
|
| 139 | PTC743 | - | - | - | - | [2] 18 18, 21 💬
|
| 140 | Resveratrol | [1] Resveratrol Resveratrol | - | - | - | [10] 2 2, 6, 8, 18, 46, 57, 89, 97, 113, 299 💬
|
| 141 | RHuG-CSF | - | - | - | - | [1] 18 18 💬
|
| 142 | Right Heart Catheterization | - | - | - | - | [1] 18 18 💬
|
| 143 | RILUZOLE | [1] Riluzole Riluzole | [1] Riluzole
Riluzole
💬
| [14] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [24] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [9] 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬
|
| 144 | Riluzole PMCS | [1] Riluzole Riluzole | [1] Riluzole
Riluzole
💬
| [14] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [24] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1] 18 18 💬
|
| 145 | RILUZOLO | - | - | - | - | [3] 2 2, 18, 114 💬
|
| 146 | Rokan (r) Novo 120 mg | - | - | - | - | [1] 18 18 💬
|
| 147 | Rosuvastatin | [1] Rosuvastatin Rosuvastatin | [2] Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [16] 6 6, 18, 46, 49, 51, 56, 57, 62, 65, 67, 79, 94, 96, 97, 271, 299 💬
|
| 148 | Saline | - | - | - | - | [12] 2 2, 6, 13, 17, 18, 53, 67, 77, 86, 97, 168, 299 💬
|
| 149 | SKYCLARYS (omaveloxolone) | [1] Omaveloxolone Omaveloxolone | [1] Omaveloxolone
Omaveloxolone
💬
| [1] NFE2L2 NFE2L2 💬
| [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 💬
|
| 150 | SLS-005 | - | - | - | - | [2] 2 2, 18 💬
|
| 151 | Sodium phenylbutyrate | [1] Phenylbutyric acid Phenylbutyric acid | [1] Sodium phenylbutyrate
Sodium phenylbutyrate
💬
| - | - | [5] 2 2, 3, 8, 18, 251 💬
|
| 152 | Standardized Ginkgo Biloba Extract (EGb 761 (r) | [1] Ginkgo biloba Ginkgo biloba | [1] Ginkgo
Ginkgo
💬
| - | - | [1] 18 18 💬
|
| 153 | Stemchymal | - | - | - | - | [1] 18 18 💬
|
| 154 | Stemchymal® | - | - | - | - | [1] 18 18 💬
|
| 155 | SUB09246MIG | - | - | - | - | [1] 18 18 💬
|
| 156 | TAK-831 | - | - | - | - | [1] 18 18 💬
|
| 157 | Taltirelin | [1] Taltirelin Taltirelin | - | - | - | [1] 18 18 💬
|
| 158 | Tocotrienol | [1] Tocotrienol Tocotrienol | - | - | - | [4] 18 18, 21, 156, 299 💬
|
| 159 | Trehalose | [1] Trehalose Trehalose | - | - | - | [4] 2 2, 6, 18, 113 💬
|
| 160 | Troriluzole | [1] Troriluzole Troriluzole | [2] Troriluzole
Troriluzole
,
Troriluzole hydrochloride
💬
| [14] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [24] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1] 18 18 💬
|
| 161 | Umbilical cord mesenchymal stem cell | - | - | - | - | [2] 18 18, 113 💬
|
| 162 | VARENICLINE | [1] Varenicline Varenicline | [2] Varenicline tartrate
Varenicline tartrate
,
Varenicline
💬
| [2] CHRNA4 CHRNA4, CHRNB2 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | [4] 6 6, 18, 53, 298 💬
|
| 163 | VATIQUINONE | [1] Vatiquinone Vatiquinone | [1] Vatiquinone
Vatiquinone
💬
| - | - | [2] 18 18, 21 💬
|
| 164 | VO659 | [1] VO659 VO659 | - | - | - | [2] 8 8, 18 💬
|